ClinicalTrials.Veeva

Menu

Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction (LAMSpigBil)

C

Catalan Institute of Health

Status

Completed

Conditions

Therapy Related Neoplasms
Endoscopy
Oncologic Disorders
Pancreatic Cancer

Treatments

Device: Endoscopic biliary transmural drainage

Study type

Observational

Funder types

Other

Identifiers

NCT04420039
HUBellvitge

Details and patient eligibility

About

There are doubts concerning the possible benefits derived from the insertion of double-pigtail plastic stents (DPS) within the lumen-apposing metal stents (LAMS) in the EUS-guided transmural biliary drainage (BD). The aims was to evaluate the safety of LAMS with and without a coaxial DPS in EUS-BD for the palliative management in malignant biliary obstruction.

Enrollment

39 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Consecutive unresectable/inoperable biliopancreatic cases with distal biliary obstruction who underwent EUS-BD after failed ERCP cannulation or inaccessible papilla

Exclusion criteria

  • Borderline cancer cases
  • Others type of biliary stents
  • Severe coagulopathy or thrombocytopenia.

Trial design

39 participants in 2 patient groups

1- Single biliary LAMS
Description:
Unresectable/inoperable biliopancreatic cases with distal biliary obstruction who underwent EUS-BD with a single lumen-apposing stent after failed ERCP cannulation or inaccessible papilla.
Treatment:
Device: Endoscopic biliary transmural drainage
2- Biliary LAMS plus Doublu-Pigtail plastic Etent
Description:
Unresectable/inoperable biliopancreatic cases with distal biliary obstruction who underwent EUS-BD with a single lumen-apposing stent (plus double-pigtail plastic stent) after failed ERCP cannulation or inaccessible papilla.
Treatment:
Device: Endoscopic biliary transmural drainage

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems